Mike Paulden Profile
Mike Paulden, BA, MSc
Research Interests and Expertise
Mr. Paulden's research interests are in the economic evaluation of health care technologies. He was previously a Health Economist and Modeller at the THETA Collaborative. He has worked on health technology assessments for the National Institute for Health Research and the National Institute for Health and Care Excellence (NICE) in the UK, and for Health Quality Ontario and the Ontario Ministry of Health and Long-Term Care in Canada. He has developed models evaluating the cost-effectiveness of a variety of health technologies and interventions, including formal screening programs for post-natal depression, neuromise inhibitors for the treatment of influenza, and genomic tests for guiding personalized chemotherapy treatment in early stage breast cancer.
His theoretical work has focused on a number of issues which carry implications for social decision making in health care, including the perspective on social choice adopted by decision makers, the cause and effect of future growth in the cost-effectiveness threshold, and the rate of time preference for health implied by health sector budget allocations. This work has addressed a long-running dispute over the use of differential discounting in cost-effectiveness analysis and has challenged current discounting practice in the U.K. and elsewhere.
Mr. Paulden recently led the economic evaluations conducted alongside the TURN and PUMTT studies. He also led THETA’s economic analysis of Oncotype DX for the Ontario Ministry of Health and Long-Term Care.